As chair of the COG Soft Tissue Sarcoma Committee, Dr. Doug Hawkins oversees biology studies and clinical trials for rhabdomyosarcoma and other soft tissue sarcomas across North America.
Hawkins is also the chair of the COG Scientific and Discipline Chairs Committee and a member of the COG Bone Tumor Steering Committee. He has led COG clinical trials for Ewing sarcoma and for rhabdomyosarcoma, both common childhood cancers.
The rhabdomyosarcoma study identified a therapy that is as effective as standard treatment, but has fewer harmful side effects. See Clinical Research Bridges New Ideas to Advances in Care.
As the principal investigator for COG activity at Seattle Children’s, Hawkins oversees all the COG-related trials we conduct.